There are 2867 resources available
1395P - Real-world association between bone targeted agents and palliative bone radiation in prostate cancer decedents: A province-wide study
Presenter: William Phillips
Session: Poster session 11
301P - Hypofractionated radiotherapy for the treatment of newly diagnosed high-grade gliomas in younger and good performance status patients during COVID-19 pandemic
Presenter: Ana Carmo Valente
Session: Poster session 03
1052P - Comprehensive molecular profiling of squamous non-small cell lung cancer by smoking status
Presenter: Joshua Reuss
Session: Poster session 15
Pro: Does hyperprogression exist?
Presenter: Christian Ottensmeier
Session: Does hyperprogression exist?
Resources:
Slides
Webcast
Systemic therapy
Presenter: Eric Baudin
Session: Management of adrenocortical carcinoma
Resources:
Slides
Webcast
1396P - Phase II study of AZD4635 in combination with durvalumab or oleclumab in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC)
Presenter: Emerson Lim
Session: Poster session 11
1053P - Early prediction of non-response to immunotherapy by a combined serum tumor marker model in non-small cell lung cancer patients
Presenter: Milou Schuurbiers
Session: Poster session 15
Contra: Does hyperprogression exist?
Presenter: Christophe Le Tourneau
Session: Does hyperprogression exist?
Resources:
Slides
Webcast
Novel compounds including immunotherapy
Presenter: Matthias Kroiss
Session: Management of adrenocortical carcinoma
Resources:
Slides
Webcast